
Gilead’s dominance of the hepatitis C market is under severe threat after a federal jury ruled in favour of MSD …
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals

